KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Account Payables (2017 - 2025)

Historic Change in Account Payables for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $1.5 million.

  • Twist Bioscience's Change in Account Payables fell 7422.52% to $1.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 million, marking a year-over-year increase of 36961.36%. This contributed to the annual value of $9.3 million for FY2025, which is 17905.12% up from last year.
  • Twist Bioscience's Change in Account Payables amounted to $1.5 million in Q4 2025, which was down 7422.52% from -$284000.0 recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Change in Account Payables ranged from a high of $6.9 million in Q3 2022 and a low of -$7.5 million during Q1 2023
  • Over the past 5 years, Twist Bioscience's median Change in Account Payables value was $525000.0 (recorded in 2021), while the average stood at $447850.0.
  • In the last 5 years, Twist Bioscience's Change in Account Payables surged by 6574000.0% in 2022 and then tumbled by 88982.83% in 2023.
  • Over the past 5 years, Twist Bioscience's Change in Account Payables (Quarter) stood at -$5000.0 in 2021, then skyrocketed by 65740.0% to $3.3 million in 2022, then plummeted by 228.12% to -$4.2 million in 2023, then skyrocketed by 235.81% to $5.7 million in 2024, then tumbled by 74.23% to $1.5 million in 2025.
  • Its Change in Account Payables was $1.5 million in Q4 2025, compared to -$284000.0 in Q3 2025 and $3.2 million in Q2 2025.